News

The paper recently published in the British Journal of Clinical Pharmacology is entitled: Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. Link to the article: http://doi.org/10.1002/bcp.70204 As indicated in the paper abstract, the authors conclude that ‘IMMUTOL gene therapy shows promising cost-effectiveness at a value-based price up to approximately €500 000, contingent on achieving curative clinical efficacy.…

EMSP is the umbrella organization for national Multiple Sclerosis (MS) organizations in Europe and has been the leading voice for people with MS for over 30 years. EMSP works with members, partners, and individuals with MS across the EU to influence policies that ensure equitable treatment, care, and resources for those affected by MS, promoting their inclusion in…

IMMUTOL coordinator, Silvia Gregori (FTELE/OSR) gave a talk at the 10th International Conference on HLA-G, 7-8 July 2025 in Ferrara, Italy about her work on IL-10-induced human tolerogenic DC: discussing their biology and application to restore tolerance. The talk was entitled ‘IL-10-induced human tolerogenic DC, DC-10, pathways involved in their induction and functions and role in pathological conditions’.…

15th Società Italiana di Immunologia, Immunologia Clinica e Allergologia (SIICA 2025) in Perugia, Italy, 17-18 June 2025 Silvia Gregori (FTELE/OSR), presented her work on latest advances in the development of engineered tolerogenic dendritic cells (tolDC) for cell-based therapies targeting autoimmune diseases. Link to event

The 2nd Annual Meeting of IMMUTOL consortium took place in Budapest between the 27th and 28th of May, 2025 hosted by SRI and organised by INN-Acta. The first day of the event was focused on progress updates given by several young scientist focused on activities in WP2 (Optimization of monocyte collection to improve advanced VitD3DC generation), WP3 (To…

Alex Agundez-Moreno (IGTP) participated in the 45th National Congress of the Spanish Society of Immunology (Sociedad Española de Inmunología (SEI)), which took place in Santander, Spain, from May 22 to 24, 2025. The poster he presented was entitled: Immune monitoring antigen-specific autoreactive T-cell responses in a cohort of multiple sclerosis patients undergoing treatment with disease-modifying…

Silvia Gregori (FTELE/OSR) gave a talk entitled ‘Engineered IL-10-producing dendritic cells for cell-based approaches to restore tolerance’ at the EFI 2025 (38th European Immunogenetics & Histocompatibility Conference) 14-17 May 2025, Prague. Link to the event

IMMUTOL was represented at the XLI congresso della Sezione Toscana SIAAIC 2025, 12-13 December 2025, Florence, where Silvia Gregori (FTELE/OSR) talked about the present and future of research in the field of gene therapy applied to autoimmune contexts. LINK to the event

SAVE THE DATE!  IMMUTOL’s 2nd Annual Meeting will take place on May 27-28, 2025, at the Lion’s Garden Hotel in Budapest, Hungary.

Luis Soria Jiménez, postdoctoral researcher and Ana María Barriocanal, MD, PhD joined the IMMUTOL projects from Institute de Investigacion en Ciencias de la Salut Germans Trias I Pujol. Welcome!